Helsinki, Finland

Daniel Veira Canle

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Nanoform Finland Plc. Active years: 2023.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Daniel Veira Canle

Introduction

Daniel Veira Canle is an accomplished inventor based in Helsinki, Finland. He has made significant contributions to the field of particle production, particularly in the pharmaceutical industry. His innovative work has led to the development of systems and methods that enhance the efficiency of producing active pharmaceutical ingredients.

Latest Patents

Daniel holds a patent for a "System, apparatuses, devices, and methods for producing particles." This patent encompasses various embodiments that include systems and methods designed to produce a population of particles, which can be crucial for pharmaceutical applications. He has 1 patent to his name, showcasing his expertise in this specialized area.

Career Highlights

Daniel is currently employed at Nanoform Finland Plc, a company known for its cutting-edge work in nanotechnology and pharmaceutical development. His role involves leveraging his innovative ideas to improve particle production processes, which are essential for the development of effective medications.

Collaborations

Daniel collaborates with talented professionals in his field, including Goran Maconi and Pia Runeberg-Roos. These collaborations enhance the innovative environment at Nanoform Finland Plc and contribute to the advancement of their projects.

Conclusion

Daniel Veira Canle is a notable inventor whose work in particle production is paving the way for advancements in pharmaceuticals. His contributions are vital to the ongoing evolution of drug development and delivery systems.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…